Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals

NeuroImage

Volumn 51, Issue 1, 2010, Pages 63-75

  Hua, Xue ^a   Lee, Suh ^a   Hibar, Derrek P ^a   Yanovsky, Igor ^c   Leow, Alex D ^a,b   Toga, Arthur W ^a   Jack Jr , Clifford R ^d   Bernstein, Matt A ^d   Reiman, Eric M ^e   Harvey, Danielle J ^f   Kornak, John ^h,i   Schuff, Norbert ^g,h   Alexander, Gene E ^e   Weiner, Michael W ^g,h,i   Thompson, Paul M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; CONTROLLED STUDY; DISEASE EXACERBATION; HUMAN; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SAMPLE SIZE; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; TEMPORAL LOBE; TIME FACTORS;

EID: 77950530012     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.01.104     Document Type: Article

References (127)

1. Aganj I., Sapiro G., Parikshak N., Madsen S.K., Thompson P.M. Measurement of cortical thickness from MRI by minimum line integrals on soft-classified tissue. Hum. Brain Mapp. 2009, 30:3188-3199.
2. Agosta F., Rocca M.A., Pagani E., Absinta M., Magnani G., Marcone A., Falautano M., Comi G., Gorno-Tempini M.L., Filippi M. Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease. Hum. Brain Mapp. 2009.
3. Apostolova L.G., Thompson P.M. Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia 2008, 46:1597-1612.
4. Apostolova L.G., Dutton R.A., Dinov I.D., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch. Neurol. 2006, 63:693-699.
5. Apostolova L.G., Steiner C.A., Akopyan G.G., Dutton R.A., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch. Neurol. 2007, 64:1489-1495.
6. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
7. Ashburner J., Friston K.J. Morphometry. Human Brain Function 2003, Academic Press.
8. Bartzokis G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 2009.
9. Bartzokis G., Cummings J.L., Sultzer D., Henderson V.W., Nuechterlein K.H., Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch. Neurol. 2003, 60:393-398.
10. Bartzokis G., Sultzer D., Lu P.H., Nuechterlein K.H., Mintz J., Cummings J.L. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol. Aging 2004, 25:843-851.
11. Bartzokis G., Lu P.H., Geschwind D.H., Edwards N., Mintz J., Cummings J.L. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch. Gen. Psychiatry 2006, 63:63-72.
12. Bartzokis G., Lu P.H., Geschwind D.H., Tingus K., Huang D., Mendez M.F., Edwards N., Mintz J. Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol. Psychiatry 2007, 62:1380-1387.
13. Berg L. Clinical dementia rating (CDR). Psychopharmacol. Bull. 1988, 24:637-639.
14. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta. Neuropathol. (Berl). 1991, 82:239-259.
15. Braskie M.N., Klunder A.D., Hayashi K.M., Protas H., Kepe V., Miller K.J., Huang S.C., Barrio J.R., Ercoli L.M., Siddarth P., Satyamurthy N., Liu J., Toga, A.W., Bookheimer S.Y., Small G.W., Thompson P.M. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol. Aging 2008, 2008 Nov 10 [Electronic publication ahead of print].
16. Brickman A.M., Siedlecki K.L., Muraskin J., Manly J.J., Luchsinger J.A., Yeung L.K., Brown T.R., Decarli C., Stern Y. White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiol. Aging 2009, [Electronic publication ahead of print].
17. Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 1998, 88:1337-1342.
18. Buckner R.L., Sepulcre J., Talukdar T., Krienen F.M., Liu H., Hedden T., Andrews-Hanna J.R., Sperling R.A., Johnson K.A. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J. Neurosci. 2009, 29:1860-1873.
19. Bullmore E.T., Suckling J., Overmeyer S., Rabe-Hesketh S., Taylor E., Brammer M.J. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans. Med. Imaging 1999, 18:32-42.
20. Busatto G.F., Diniz B.S., Zanetti M.V. Voxel-based morphometry in Alzheimer's disease. Expert Rev. Neurother. 2008, 8:1691-1702.
21. Carmichael O.T., Thompson P.M., Dutton R.A., Lu A., Lee S.E., Lee J.Y., Kuller L.H., Lopez O.L., Aizenstein H.J., Meltzer C.C., Liu Y., Toga A.W., Becker J.T. Mapping ventricular changes related to dementia and mild cognitive impairment in a large community-based cohort. IEEE ISBI 2006, 315-318.
22. Chetelat G., Landeau B., Eustache F., Mezenge F., Viader F., de la Sayette V., Desgranges B., Baron J.C. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005, 27:934-946.
23. Chetelat G., Desgranges B., Landeau B., Mezenge F., Poline J.B., de la Sayette V., Viader F., Eustache F., Baron J.C. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008, 131:60-71.
24. Chetelat G., Fouquet M., Kalpouzos G., Denghien I., De la Sayette V., Viader F., Mezenge F., Landeau B., Baron J.C., Eustache F., Desgranges B. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry. Neuropsychologia 2008, 46:1721-1731.
25. Chen, K., Langbaum, J., Fleisher, A.S., Reschke, C., Lee, W., Liu, X., Ayutyanont, N., Bandy, D., Alexander, G.E., Thompson, P.M., Foster, N.L., Harvey, D.J., De Leon, M.J., Koeppe, R.A., Jagust, W.J., Weiner, M.W., Reiman, E.M., and the Alzheimer's Disease Neuroimaging Initiative, 2009a. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative (submitted).
26. Chen, K., Reschke, C., Lee, W., Napatkamon, A., Liu, X., Bandy, D., Langbaum, J., Alexander, G.E., Foster, N.L., Koeppe, R.A., Jagust, W.J., Weiner, M.W., Reiman, E.M., 2009b. Cross-sectional and longitudinal analyses of fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative. ADNI Data Presentations Meeting, Seattle, WA.
27. Chiang M.C., Dutton R.A., Hayashi K.M., Lopez O.L., Aizenstein H.J., Toga A.W., Becker J.T., Thompson P.M. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 2007, 34:44-60.
28. Chou Y.Y., Lepore N., de Zubicaray G.I., Carmichael O.T., Becker J.T., Toga A.W., Thompson P.M. Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease. Neuroimage 2008, 40:615-630.
29. Chou, Y.Y., Leporé, N., Avedissian, C., Madsen, S.K., Hua, X., Jack, C.R., Weiner, M.W., Toga, A.W., Thompson, P.M., 2009a. Mapping ventricular expansion and its clinical correlates in Alzheimer's disease and mild cognitive impairment using multi-atlas fluid image alignment. SPIE Medical Imaging, February 7-12 2009., Lake Buena Vista, Florida.
30. Chou Y.Y., Lepore N., Avedissian C., Madsen S.K., Parikshak N., Hua X., Shaw L.M., Trojanowski J.Q., Weiner M.W., Toga A.W., Thompson P.M. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage 2009, 46:394-410.
31. Chung M.K., Worsley K.J., Paus T., Cherif C., Collins D.L., Giedd J.N., Rapoport J.L., Evans A.C. A unified statistical approach to deformation-based morphometry. Neuroimage 2001, 14:595-606.
32. Clarkson M.J., Ourselin S., Nielsen C., Leung K.K., Barnes J., Whitwell J.L., Gunter J.L., Hill D.L., Weiner M.W., Jack C.R., Fox N.C. Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage 2009, 47:1506-1513.
33. Cockrell J.R., Folstein M.F. Mini-Mental State Examination (MMSE). Psychopharmacol. Bull. 1988, 24:689-692.
34. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 1994, 18:192-205.
35. Davatzikos C., Genc A., Xu D., Resnick S.M. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage 2001, 14:1361-1369.
36. Davatzikos C., Fan Y., Wu X., Shen D., Resnick S.M. Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol. Aging 2008, 29:514-523.
37. Davison A.C., Hinkley D.V. Bootstrap Methods and their Application 1997, Cambridge University Press.
38. Dickerson B.C., Bakkour A., Salat D.H., Feczko E., Pacheco J., Greve D.N., Grodstein F., Wright C.I., Blacker D., Rosas H.D., Sperling R.A., Atri A., Growdon J.H., Hyman B.T., Morris J.C., Fischl B., Buckner R.L. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 2009, 19:497-510.
39. Efron B., Tibshirani R.J. An Introduction to the Bootstrap 1993, Chapman & Hall, New York.
40. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
41. Fitzmaurice G.M., Laird N.M., Ware J.H. Applied Longitudinal Analysis 2004, Wiley-Interscience.
42. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
43. Fox N.C., Freeborough P.A. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J. Magn. Reson. Imaging 1997, 7:1069-1075.
44. Fox N.C., Warrington E.K., Freeborough P.A., Hartikainen P., Kennedy A.M., Stevens J.M., Rossor M.N. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996, 119(Pt. 6):2001-2007.
45. Fox N.C., Scahill R.I., Crum W.R., Rossor M.N. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 1999, 52:1687-1689.
46. Fox N.C., Cousens S., Scahill R., Harvey R.J., Rossor M.N. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch. Neurol. 2000, 57:339-344.
47. Frank R.A., Galasko D., Hampel H., Hardy J., de Leon M.J., Mehta P.D., Rogers J., Siemers E., Trojanowski J.Q. Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol. Aging 2003, 24:521-536.
48. Freeborough P.A., Fox N.C. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. J. Comput. Assist. Tomogr. 1998, 22:838-843.
49. Freeborough P.A., Fox N.C., Kitney R.I. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput. Methods Programs Biomed. 1997, 53:15-25.
50. Frisoni G.B., Pievani M., Testa C., Sabattoli F., Bresciani L., Bonetti M., Beltramello A., Hayashi K.M., Toga A.W., Thompson P.M. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007, 130:720-730.
51. Frisoni G.B., Prestia A., Rasser P.E., Bonetti M., Thompson P.M. In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease. J. Neurol. 2009, 256:916-924.
52. Frisoni G.B., Fox N.C., Jack C.R., Scheltens P., Thompson P.M. The clinical use of structural MRI in Alzheimer disease. Rev. Neurol. 2010, 6:1-11.
53. Frost C., Kenward M.G., Fox N.C. The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging. Stat. Med. 2004, 23:3275-3286.
54. Grundman M., Petersen R.C., Ferris S.H., Thomas R.G., Aisen P.S., Bennett D.A., Foster N.L., Jack C.R., Galasko D.R., Doody R., Kaye J., Sano M., Mohs R., Gauthier S., Kim H.T., Jin S., Schultz A.N., Schafer K., Mulnard R., van Dyck C.H., Mintzer J., Zamrini E.Y., Cahn-Weiner D., Thal L.J. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch. Neurol. 2004, 61:59-66.
55. Gunter J.L., Bernstein M.A., Borowski B.J., Ward C.P., Britson P.J., Felmlee J.P., Schuff N., Weiner M., Jack C.R. Measurement of MRI scanner performance with the ADNI phantom. Med. Phys. 2009, 36(6):2193-2205.
56. MetLife Foundation Alzheimer's Survey: What America Thinks 2006, Harris, Interactive.
57. Hedden T., Van Dijk K.R., Becker J.A., Mehta A., Sperling R.A., Johnson K.A., Buckner R.L. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J. Neurosci. 2009, 29:12686-12694.
58. Ho, A.J., Hua, X., Lee, S., Yanovsky, I., Leow, A.D., Gutman, B., Dinov, I.D., Toga, A.W., Jack, C.R., Jr., Bernstein, M.A., Reiman, E.M., Harvey, D., Kornak, J., Schuff, N., Alexander, G.E., Weiner, M.W., Thompson, P.M., in press. Comparing 3T and 1.5T MRI for tracking AD progression with tensor-based morphometry. NeuroImage [Electronic publication ahead of print].
59. Hua X., Leow A.D., Lee S., Klunder A.D., Toga A.W., Lepore N., Chou Y.Y., Brun C., Chiang M.C., Barysheva M., Jack C.R., Bernstein M.A., Britson P.J., Ward C.P., Whitwell J.L., Borowski B., Fleisher A.S., Fox N.C., Boyes R.G., Barnes J., Harvey D., Kornak J., Schuff N., Boreta L., Alexander G.E., Weiner M.W., Thompson P.M. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 2008, 41:19-34. and the Alzheimer's Disease Neuroimaging Initiative.
60. Hua X., Leow A.D., Parikshak N., Lee S., Chiang M.C., Toga A.W., Jack C.R., Weiner M.W., Thompson P.M. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage 2008, 43:458-469.
61. Hua X., Lee S., Yanovsky I., Leow A.D., Chou Y.Y., Ho A.J., Gutman B., Toga A.W., Jack C.R., Bernstein M.A., Reiman E.M., Harvey D.J., Kornak J., Schuff N., Alexander G.E., Weiner M.W., Thompson P.M. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage 2009, 48:668-681.
62. Hua X., Leow A.D., Levitt J.G., Caplan R., Thompson P.M., Toga A.W. Detecting brain growth patterns in normal children using tensor-based morphometry. Hum. Brain Mapp. 2009, 30:209-219.
63. Huang J., Friedland R.P., Auchus A.P. Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am. J. Neuroradiol. 2007, 28:1943-1948.
64. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
65. Ishii K., Kawachi T., Sasaki H., Kono A.K., Fukuda T., Kojima Y., Mori E. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am. J. Neuroradiol. 2005, 26:333-340.
66. Jack C.R., Petersen R.C., Xu Y.C., Waring S.C., O'Brien P.C., Tangalos E.G., Smith G.E., Ivnik R.J., Kokmen E. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997, 49:786-794.
67. Jack C.R., Petersen R.C., Xu Y., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998, 51:993-999.
68. Jack C.R., Slomkowski M., Gracon S., Hoover T.M., Felmlee J.P., Stewart K., Xu Y., Shiung M., O'Brien P.C., Cha R., Knopman D., Petersen R.C. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003, 60:253-260.
69. Jack C.R., Bernstein M.A., Fox N.C., Thompson P., Alexander G., Harvey D., Borowski B., Britson P.J., Whitwell J.L, Ward C., Dale A.M., Felmlee J.P., Gunter J.L., Hill D.L., Killiany R., Schuff N., Fox-Bosetti S., Lin C., Studholme C., DeCarli C.S., Krueger G., Ward H.A., Metzger G.J., Scott K.T., Mallozzi R., Blezek D., Levy J., Debbins J.P., Fleisher A.S., Albert M., Green R., Bartzokis G., Glover G., Mugler J., Weiner M.W. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 2008, 27:685-691.
70. Jack C.R., Lowe V.J., Weigand S.D., Wiste H.J., Senjem M.L., Knopman D.S., Shiung M.M., Gunter J.L., Boeve B.F., Kemp B.J., Weiner M., Petersen R.C. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132:1355-1365.
71. Jellinger K.A. Alzheimer 100-highlights in the history of Alzheimer research. J. Neural. Transm. 2006, 113:1603-1623.
72. Jorm A.F., Korten A.E., Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 1987, 76:465-479.
73. Jovicich J., Czanner S., Greve D., Haley E., van der Kouwe A., Gollub R., Kennedy D., Schmitt F., Brown G., Macfall J., Fischl B., Dale A. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006, 30:436-443.
74. Killiany R.J., Moss M.B., Albert M.S., Sandor T., Tieman J., Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch. Neurol. 1993, 50:949-954.
75. Leow A.D., Klunder A.D., Jack C.R., Toga A.W., Dale A.M., Bernstein M.A., Britson P.J., Gunter J.L., Ward C.P., Whitwell J.L., Borowski B.J., Fleisher A.S., Fox N.C., Harvey D., Kornak J., Schuff N., Studholme C., Alexander G.E., Weiner M.W., Thompson P.M. Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage 2006, 31:627-640.
76. Leow A.D., Yanovsky I., Parikshak N., Hua X., Lee S., Toga A.W., Jack C.R., Bernstein M.A., Britson P.J., Gunter J.L., Ward C.P., Borowski B., Shaw L.M., Trojanowski J.Q., Fleisher A.S., Harvey D., Kornak J., Schuff N., Alexander G.E., Weiner M.W., Thompson P.M. Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage 2009, 45:645-655.
77. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., Woods R., Paus T., Simpson G., Pike B., Holmes C., Collins L., Thompson P., MacDonald D., Iacoboni M., Schormann T., Amunts K., Palomero-Gallagher N., Geyer S., Parsons L., Narr K., Kabani N., Le Goualher G., Boomsma D., Cannon T., Kawashima R., Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2001, 356:1293-1322.
78. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
79. Misra C., Fan Y., Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009, 44:1415-1422.
80. Morra J.H., Tu Z., Apostolova L.G., Green A.E., Avedissian C., Madsen S.K., Parikshak N., Hua X., Toga A.W., Jack C.R., Schuff N., Weiner M.W., Thompson P.M. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum. Brain Mapp. 2009, 30:2766-2788.
81. Morra J.H., Tu Z., Apostolova L.G., Green A.E., Avedissian C., Madsen S.K., Parikshak N., Toga A.W., Jack C.R., Schuff N., Weiner M.W., Thompson P.M. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage 2009, 45:S3-S15.
82. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
83. Mueller S.G., Weiner M.W., Thal L.J., Petersen R.C., Jack C., Jagust W., Trojanowski J.Q., Toga A.W., Beckett L. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin. N. Am. 2005, 15:869-877. xi-xii.
84. Mueller S.G., Weiner M.W., Thal L.J., Petersen R.C., Jack C.R., Jagust W., Trojanowski J.Q., Toga A.W., Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005, 1:55-66.
85. Naggara O., Oppenheim C., Rieu D., Raoux N., Rodrigo S., Dalla Barba G., Meder J.F. Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res. 2006, 146:243-249.
86. Nestor S.M., Rupsingh R., Borrie M., Smith M., Accomazzi V., Wells J.L., Fogarty J., Bartha R. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 2008, 131:2443-2454.
87. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
88. Paling S.M., Williams E.D., Barber R., Burton E.J., Crum W.R., Fox N.C., O'Brien J.T. The application of serial MRI analysis techniques to the study of cerebral atrophy in late-onset dementia. Med. Image Anal. 2004, 8:69-79.
89. Petersen R.C. Mild cognitive impairment clinical trials. Nat. Rev. Drug Discov. 2003, 2:646-653.
90. Petersen R.C. Mild Cognitive Impairment: Aging to Alzheimer's Disease 2003, Oxford University Press, New York.
91. Petersen R.C. Mild cognitive impairment: current research and clinical implications. Semin. Neurol. 2007, 27:22-31.
92. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 2001, 58:1985-1992.
93. Protas H.D., Huang S.C., Kepe V., Hayashi K., Klunder A., Braskie M.N., Ercoli L., Bookheimer S., Thompson P.M., Small G.W., Barrio J.R. FDDNP binding using MR derived cortical surface maps. Neuroimage 2009, 49:240-248.
94. Reiman, E.M., Chen, K., Ayutyanont, N., Bandy, D., Lee, W., Reschke, C., Alexander, G.E., Weiner, M.W., Koeppe, R.A., Jagust, W.J., 2008a. Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: preliminary findings from the Alzheimer's disease neuroimaging initiative. ICAD, Chicago, Illinois.
95. Reiman, E.M., Chen, K., Ayutyanont, N., Lee, W., Bandy, D., Reschke, C., Alexander, G.E., Weiner, M.W., Koeppe, R.A., Foster, N.L., Jagust, W.J., 2008b. Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative (ADNI), Alzheimer's and Dementia 4, T110-T111.
96. Riddle W.R., Li R., Fitzpatrick J.M., DonLevy S.C., Dawant B.M., Price R.R. Characterizing changes in MR images with color-coded Jacobians. Magn. Reson. Imaging 2004, 22:769-777.
97. Rose S.E., Chen F., Chalk J.B., Zelaya F.O., Strugnell W.E., Benson M., Semple J., Doddrell D.M. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J. Neurol. Neurosurg. Psychiatry 2000, 69:528-530.
98. Rosen W.G., Mohs R.C., Davis K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 1984, 141:1356-1364.
99. Rosner B. Fundamentals of Biostatistics 1990, PWS-Kent Publishing Company, Boston.
100. Sandson T.A., Felician O., Edelman R.R., Warach S. Diffusion-weighted magnetic resonance imaging in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 1999, 10:166-171.
101. Scahill R.I., Fox N.C. Longitudinal imaging in dementia. Br. J. Radiol. 2007, 2:S92-98. 80 Spec No.
102. Scahill R.I., Frost C., Jenkins R., Whitwell J.L., Rossor M.N., Fox N.C. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 2003, 60:989-994.
103. Schott J.M., Frost C., Whitwell J.L., Macmanus D.G., Boyes R.G., Rossor M.N., Fox N.C. Combining short interval MRI in Alzheimer's disease: implications for therapeutic trials. J. Neurol. 2006, 253:1147-1153.
104. Schuff N., Woerner N., Boreta L., Kornfield T., Shaw L.M., Trojanowski J.Q., Thompson P.M., Jack C.R., Weiner M.W. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 2009, 132(4):1067-1077.
105. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell. Biol. 2004, 6:1054-1061.
106. Shattuck D.W., Leahy R.M. BrainSuite: an automated cortical surface identification tool. Med. Image Anal. 2002, 6:129-142.
107. Shaw L.M., Korecka M., Clark C.M., Lee V.M., Trojanowski J.Q. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat. Rev. Drug Discov. 2007, 6:295-303.
108. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
109. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23(Suppl. 1):S208-S219.
110. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002, 17:479-489.
111. Spires-Jones T.L., Stoothoff W.H., de Calignon A., Jones P.B., Hyman B.T. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 2009, 32:150-159.
112. Supekar K., Menon V., Rubin D., Musen M., Greicius M.D. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput. Biol. 2008, 4:e1000100.
113. Thompson P.M., Apostolova L.G. Computational anatomical methods as applied to aging and dementia. Br. J. Radiol. 2007, 80. Spec No 2, S78-91.
114. Thompson P.M., Giedd J.N., Woods R.P., MacDonald D., Evans A.C., Toga A.W. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 2000, 404:190-193.
115. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., Toga A.W. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23:994-1005.
116. Thompson P.M., Hayashi K.M., De Zubicaray G.I., Janke A.L., Rose S.E., Semple J., Hong M.S., Herman D.H., Gravano D., Doddrell D.M., Toga A.W. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004, 22:1754-1766.
117. Thompson P.M., Bartzokis G., Hayashi K.M., Klunder A.D., Lu P.H., Edwards N., Hong M.S., Yu M., Geaga J.A., Toga A.W., Charles C., Perkins D.O., McEvoy J., Hamer R.M., Tohen M., Tollefson G.D., Lieberman J.A. Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb. Cortex 2009, 19:1107-1123.
118. Toga A.W. Brain Warping 1999, Academic Press, San Diego. 1st ed.
119. Vemuri P., Whitwell J.L., Kantarci K., Josephs K.A., Parisi J.E., Shiung M.S., Knopman D.S., Boeve B.F., Petersen R.C., Dickson D.W., Jack C.R. Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage 2008, 42:559-567.
120. Wang K., Liang M., Wang L., Tian L., Zhang X., Li K., Jiang T. Altered functional connectivity in early Alzheimer's disease: a resting-state fMRI study. Hum. Brain Mapp. 2007, 28:967-978.
121. Wang L., Goldstein F.C., Veledar E., Levey A.I., Lah J.J., Meltzer C.C., Holder C.A., Mao H. Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. AJNR Am. J. Neuroradiol. 2009, 30:893-899.
122. Whitwell J.L., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007, 130:1777-1786.
123. Whitwell J.L., Josephs K.A., Murray M.E., Kantarci K., Przybelski S.A., Weigand S.D., Vemuri P., Senjem M.L., Parisi J.E., Knopman D.S., Boeve B.F., Petersen R.C., Dickson D.W., Jack C.R. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 2008, 71:743-749.
124. Wozniak J.R., Lim K.O. Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci. Biobehav. Rev. 2006, 30:762-774.
125. Yanovsky I., Thompson P., Osher S., Leow A.D. Asymmetric and symmetric unbiased image registration: statistical assessment of performance. IEEE Comput. Soc. Workshop Math. Methods Biomed. Image Anal. 2008, 1:1-8.
126. Yanovsky I., Leow A.D., Lee S., Osher S.J., Thompson P.M. Comparing registration methods for mapping brain change using tensor-based morphometry. Medical Image Analysis 2009, 13:679-700.
127. Zhou Y., Dougherty J.H., Hubner K.F., Bai B., Cannon R.L., Hutson R.K. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment. Alzheimers Dement. 2008, 4:265-270.